Zaidi AH - Search Results

1

The Evolving Landscape of Neoadjuvant Immunotherapy in Gastroesophageal Cancer.

Dennehy C, Khan AF, Zaidi AH, Lam VK. Dennehy C, et al. Among authors: zaidi ah. Cancers (Basel). 2024 Jan 9;16(2):286. doi: 10.3390/cancers16020286. Cancers (Basel). 2024. PMID: 38254776 Free PMC article. Review.

2

Tumor Microenvironment before and after Chemoradiation in Locally Advanced Rectal Cancer: Beyond PD-L1.

Tayshetye P, Friday AJ, Omstead AN, Verma T, Miller S, Zheng P, Jani P, Zaidi A, Finley G. Tayshetye P, et al. Cancers (Basel). 2022 Dec 31;15(1):276. doi: 10.3390/cancers15010276. Cancers (Basel). 2022. PMID: 36612271 Free PMC article.

3

Elucidating the Heterogeneity of Immunotherapy Response and Immune-Related Toxicities by Longitudinal ctDNA and Immune Cell Compartment Tracking in Lung Cancer.

Murray JC, Sivapalan L, Hummelink K, Balan A, White JR, Niknafs N, Rhymee L, Pereira G, Rao N, Weksler B, Bahary N, Phallen J, Leal A, Bartlett DL, Marrone KA, Naidoo J, Goel A, Levy B, Rosner S, Hann CL, Scott SC, Feliciano J, Lam VK, Ettinger DS, Li QK, Illei PB, Monkhorst K, Scharpf RB, Brahmer JR, Velculescu VE, Zaidi AH, Forde PM, Anagnostou V. Murray JC, et al. Among authors: zaidi ah. Clin Cancer Res. 2024 Jan 17;30(2):389-403. doi: 10.1158/1078-0432.CCR-23-1469. Clin Cancer Res. 2024. PMID: 37939140 Free PMC article.

4

Sitravatinib combined with PD-1 blockade enhances cytotoxic T-cell infiltration by M2 to M1 tumor macrophage repolarization in esophageal adenocarcinoma.

Sweeney R, Omstead AN, Fitzpatrick JT, Zheng P, Gorbunova A, Grayhack EE, Goel A, Khan AF, Kosovec JE, Wagner PL, Jobe BA, Kelly RJ, Zaidi AH. Sweeney R, et al. Among authors: zaidi ah. Carcinogenesis. 2024 Apr 12;45(4):210-219. doi: 10.1093/carcin/bgad087. Carcinogenesis. 2024. PMID: 38019590

5

Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses.

Kelly RJ, Landon BV, Zaidi AH, Singh D, Canzoniero JV, Balan A, Hales RK, Voong KR, Battafarano RJ, Jobe BA, Yang SC, Broderick S, Ha J, Marrone KA, Pereira G, Rao N, Borole A, Karaindrou K, Belcaid Z, White JR, Ke S, Amjad AI, Weksler B, Shin EJ, Thompson E, Smith KN, Pardoll DM, Hu C, Feliciano JL, Anagnostou V, Lam VK. Kelly RJ, et al. Among authors: zaidi ah. Nat Med. 2024 Apr;30(4):1023-1034. doi: 10.1038/s41591-024-02877-z. Epub 2024 Mar 19. Nat Med. 2024. PMID: 38504015 Free PMC article. Clinical Trial.

6

Characterizing the Immune Environment in Peritoneal Carcinomatosis: Insights for Novel Immunotherapy Strategies.

Wagner PL, Knotts CM, Donneberg VS, Dadgar N, Pico CC, Xiao K, Zaidi A, Schiffman SC, Allen CJ, Donnenberg AD, Bartlett DL. Wagner PL, et al. Ann Surg Oncol. 2024 Mar;31(3):2069-2077. doi: 10.1245/s10434-023-14553-6. Epub 2023 Nov 23. Ann Surg Oncol. 2024. PMID: 37996643

7

The Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation.

Kelly RJ, Zaidi AH, Smith MA, Omstead AN, Kosovec JE, Matsui D, Martin SA, DiCarlo C, Werts ED, Silverman JF, Wang DH, Jobe BA. Kelly RJ, et al. Among authors: zaidi ah. Ann Surg. 2018 Dec;268(6):992-999. doi: 10.1097/SLA.0000000000002410. Ann Surg. 2018. PMID: 28806299

8

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma.

Matani H, Sahu D, Paskewicz M, Gorbunova A, Omstead AN, Wegner R, Finley GG, Jobe BA, Kelly RJ, Zaidi AH, Goel A. Matani H, et al. Among authors: zaidi ah. Biomark Res. 2022 Nov 14;10(1):81. doi: 10.1186/s40364-022-00429-6. Biomark Res. 2022. PMID: 36376989 Free PMC article.

9

Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.

Matsui D, Zaidi AH, Martin SA, Omstead AN, Kosovec JE, Huleihel L, Saldin LT, DiCarlo C, Silverman JF, Hoppo T, Finley GG, Badylak SF, Kelly RJ, Jobe BA. Matsui D, et al. Among authors: zaidi ah. Oncotarget. 2016 Dec 6;7(49):81281-81291. doi: 10.18632/oncotarget.12832. Oncotarget. 2016. PMID: 27793030 Free PMC article. Review.

10

The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy.

Kosovec JE, Zaidi AH, Pounardjian TS, Jobe BA. Kosovec JE, et al. Among authors: zaidi ah. Front Oncol. 2018 Dec 11;8:610. doi: 10.3389/fonc.2018.00610. eCollection 2018. Front Oncol. 2018. PMID: 30619750 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page